Works matching IS 00316970 AND DT 2000 AND VI 55 AND IP 11/12

Results: 18

Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer's disease.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 815, doi. 10.1007/s002280050702

By:

Alafuzoff, I.;
Helisalmi, S.;
Heinonen, E. H.;
Reinikainen, K.;
Hallikainen, M.;
Soininen, H.;
Koivisto, K.

Publication type:

Article

How did such a bad report get published in the EJCP? : Trial of paracetamol, ibuprofen and nimesulide in children with upper respiratory infections (B. Ulukol et al., EJCP November 1999, 55: 615–618).

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 881, doi. 10.1007/s002280050712

By:

Herxheimer, A.

Publication type:

Article

Probucol reduces lysophosphatidylcholines in low-density lipoprotein.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 787

By:

Yoshinari, M.;
Shi, A. -H.;
Yoshizumi, H.;
Wakisaka, M.;
Iwase, M.;
Fujishima, M.

Publication type:

Article

The impact of problem-based pharmacotherapy training on the competence of rational prescribing of Yemen undergraduate students.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 873, doi. 10.1007/s002280050710

By:

Hassan, N. A. G. M.;
Abdulla, A. A.;
Bakathir, H. A.;
Al-Amoodi, A. A.;
Aklan, A. M.;
de Vries, T. P. G. M.

Publication type:

Article

Influence of CYP2D62 and CYP2D64 alleles on phenotype in polymedicated depressed inpatients: therapeutic consequences?

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 877, doi. 10.1007/s002280050711

By:

Haffen, E.;
Vandel, P.;
Paintaud, G.;
Broly, F.;
Vandel, S.;
Bonin, B.;
Bizouard, P.;
Sechter, D.;
Bechtel, P. R.

Publication type:

Article

Human halothane metabolism, lipid peroxidation, and cytochromes P4502A6 and P4503A4.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 853, doi. 10.1007/s002280050707

By:

Kharasch, E. D.;
Hankins, D. C.;
Fenstamaker, K.;
Cox, K.

Publication type:

Article

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug–drug interactions.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 843, doi. 10.1007/s002280050706

By:

Katoh, M.;
Nakajima, M.;
Shimada, N.;
Yamazaki, H.;
Yokoi, T.

Publication type:

Article

Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteers.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 837, doi. 10.1007/s002280050705

By:

Jansen, B.;
Graselli, U.;
Dallinger, S.;
Kiss, B.;
Wacheck, V.;
Schlagbauer-Wadl, H.;
Assandri, A.;
Müller, M.

Publication type:

Article

Structure–effect relationships of amiodarone analogues on the inhibition of thyroxine deiodination.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 807, doi. 10.1007/s002280050701

By:

Ha, H. R.;
Stieger, B.;
Grassi, G.;
Altorfer, H. R.;
Follath, F.

Publication type:

Article

Co-ordinating editor's comments on the letter to the editors by A. Herxheimer.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 883, doi. 10.1007/s002280050713

By:

Dahlqvist, Rune

Publication type:

Article

Simultaneous modelling of flosequinan and its metabolite.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 827, doi. 10.1007/s002280050704

By:

Lindsey, J. K.;
Wang, J.;
Jones, B.;
Byrom, W. D.;
Hind, I. D.

Publication type:

Article

CYP2C19 polymorphism effect on phenobarbitone : Pharmacokineties in Japanese patients with epilepsy: analysis by population pharmacokinetics.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 821, doi. 10.1007/s002280050703

By:

Mamiya, K.;
Hadama, A.;
Yukawa, E.;
Ieiri, I.;
Otsubo, K.;
Ninomiya, H.;
Tashiro, N.;
Higuchi, S.

Publication type:

Article

The efficacy of buffered ketoprofen in postoperative pain after third molar surgery.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 801, doi. 10.1007/s002280050700

By:

Seymour, R. A.;
Watkinson, H.;
Hawkesford, J. E.;
Moore, U.

Publication type:

Article

Haemodynamic interactions between the novel calcium sensitiser levosimendan and isosorbide-5-mononitrate in healthy subjects.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 793

By:

Sundberg, S.;
Lehtonen, L.

Publication type:

Article

Methodological and political issues in clinical pharmacology research by the year 2000.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 781

By:

Carné, X.;
Arnaiz, J. -A.

Publication type:

Article

Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 867, doi. 10.1007/s002280050709

By:

Hoke, J. F.;
Dyker, A. G.;
Barnaby, R. J.;
Lees, K. R.

Publication type:

Article

Circadian variation of the urinary 6β-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 861, doi. 10.1007/s002280050708

By:

Ohno, M.;
Yamaguchi, I.;
Ito, T.;
Saiki, K.;
Yamamoto, I.;
Azuma, J.

Publication type:

Article

Master – shall I write your article? Pushing the genie back into the bottle.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 55, n. 11/12, p. 779, doi. 10.1007/s002280050696

By:

Offerhaus, L.

Publication type:

Article

Works matching IS 00316970 AND DT 2000 AND VI 55 AND IP 11/12

Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer's disease.

How did such a bad report get published in the EJCP? : Trial of paracetamol, ibuprofen and nimesulide in children with upper respiratory infections (B. Ulukol et al., EJCP November 1999, 55: 615–618).

Probucol reduces lysophosphatidylcholines in low-density lipoprotein.

The impact of problem-based pharmacotherapy training on the competence of rational prescribing of Yemen undergraduate students.

Influence of CYP2D62 and CYP2D64 alleles on phenotype in polymedicated depressed inpatients: therapeutic consequences?

Human halothane metabolism, lipid peroxidation, and cytochromes P<sub>450</sub>2A6 and P<sub>450</sub>3A4.

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug–drug interactions.

Pharmacokinetics and pharmacodynamics of the novel H<sub>1</sub>-receptor antagonist emedastine in healthy volunteers.

Structure–effect relationships of amiodarone analogues on the inhibition of thyroxine deiodination.

Co-ordinating editor's comments on the letter to the editors by A. Herxheimer.

Simultaneous modelling of flosequinan and its metabolite.

CYP2C19 polymorphism effect on phenobarbitone : Pharmacokineties in Japanese patients with epilepsy: analysis by population pharmacokinetics.

The efficacy of buffered ketoprofen in postoperative pain after third molar surgery.

Haemodynamic interactions between the novel calcium sensitiser levosimendan and isosorbide-5-mononitrate in healthy subjects.

Methodological and political issues in clinical pharmacology research by the year 2000.

Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke.

Circadian variation of the urinary 6β-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity.

Master – shall I write your article? Pushing the genie back into the bottle.